# Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

> **NCT01886105** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 4 (actual)

## Conditions studied

- Metastatic Osteosarcoma

## Interventions

- **DRUG:** Sm-EDTMP
- **OTHER:** Autologous Stem Cell Infusion
- **RADIATION:** External Beam Radiotherapy

## Key facts

- **NCT ID:** NCT01886105
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08-19
- **Primary completion:** 2015-12-11
- **Final completion:** 2017-06-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low accrual and loss of funding
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01886105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01886105, "Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01886105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*